A Potent Antioxidant Endogenous Neurohormone Melatonin, Rescued MCAO by Attenuating Oxidative Stress-Associated Neuroinflammation
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ling, Li | - |
dc.contributor.author | Alattar, Abdullah | - |
dc.contributor.author | Tan, Zhen | - |
dc.contributor.author | Shah, Fawad Ali | - |
dc.contributor.author | Ali, Tahir | - |
dc.contributor.author | Alshaman, Reem | - |
dc.contributor.author | Koh, Phil Ok | - |
dc.contributor.author | Li, Shupeng | - |
dc.date.accessioned | 2022-12-26T12:31:56Z | - |
dc.date.available | 2022-12-26T12:31:56Z | - |
dc.date.created | 2022-12-12 | - |
dc.date.issued | 2020-08-21 | - |
dc.identifier.issn | 1663-9812 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gnu/handle/sw.gnu/6297 | - |
dc.description.abstract | Ischemic stroke is an acute neurological syndrome either due to permanent or temporary obstruction of blood. Such obstruction immediately triggers abrupt pathological cascading processes, which collectively lead to neuronal cell death. Oxidative stress and neuroinflammation in ischemic stroke are critical regulating events that ultimately lead to neuronal death. Complicated interplay exists between the two processes which occur through several stages. Most often, oxidative stress precedes the inflammatory mechanisms and includes several interconnected cascades that underlie the ischemic stroke pathology. In continuation of the previously published data, here, we further ruled out the protective role of melatonin in focal cerebral ischemic injury model. Administration of 5 mg/kg dose of melatonin 30 min prior to ischemia reduced brain infarction associated with sequentially rescued neuronal apoptosis. Furthermore, melatonin attenuated neuroinflammatory markers and reactive oxygen species (ROS), induced by ischemic stroke,viahalting the key players of mitogen stress family (p38/JNK). Besides, melatonin modulated the endogenously produced antioxidant enzyme, thioredoxin (Trx) pathway. These broader therapeutic efficacies of melatonin suggest that melatonin could be further investigated for its diverse therapeutic actions with multiple targets in recovering, preventing and halting the detrimental outcomes of MCAO, such as elevated oxidative stress, neuroinflammation, and neurodegeneration. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | FRONTIERS MEDIA SA | - |
dc.subject | CEREBRAL-ARTERY OCCLUSION | - |
dc.subject | ISCHEMIC-STROKE | - |
dc.subject | ANIMAL-MODELS | - |
dc.subject | NRF2-KEAP1 PATHWAY | - |
dc.subject | RECEPTOR | - |
dc.subject | EXPRESSION | - |
dc.subject | PROTECTS | - |
dc.subject | ACTIVATION | - |
dc.subject | MECHANISMS | - |
dc.subject | BRAIN | - |
dc.title | A Potent Antioxidant Endogenous Neurohormone Melatonin, Rescued MCAO by Attenuating Oxidative Stress-Associated Neuroinflammation | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Koh, Phil Ok | - |
dc.identifier.doi | 10.3389/fphar.2020.01220 | - |
dc.identifier.scopusid | 2-s2.0-85090384971 | - |
dc.identifier.wosid | 000568274800001 | - |
dc.identifier.bibliographicCitation | FRONTIERS IN PHARMACOLOGY, v.11 | - |
dc.relation.isPartOf | FRONTIERS IN PHARMACOLOGY | - |
dc.citation.title | FRONTIERS IN PHARMACOLOGY | - |
dc.citation.volume | 11 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | CEREBRAL-ARTERY OCCLUSION | - |
dc.subject.keywordPlus | ISCHEMIC-STROKE | - |
dc.subject.keywordPlus | ANIMAL-MODELS | - |
dc.subject.keywordPlus | NRF2-KEAP1 PATHWAY | - |
dc.subject.keywordPlus | RECEPTOR | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | PROTECTS | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.subject.keywordPlus | MECHANISMS | - |
dc.subject.keywordPlus | BRAIN | - |
dc.subject.keywordAuthor | melatonin | - |
dc.subject.keywordAuthor | middle cerebral artery occlusion | - |
dc.subject.keywordAuthor | neuroinflammation | - |
dc.subject.keywordAuthor | antioxidant | - |
dc.subject.keywordAuthor | ischemic stroke | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0533
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.